Center-Authored Papers

Browse: Authors | Keywords | All Center-Authored Publications
Filter by Division: Basic | Clinical | Human Biology | PHS | VIDD (2010-present) | VIDI (2008-2009)
Filter by Year: 2008 | 2009 | 2010 | 2011 | 2012 | 2013

Filters: Keyword is Immunosuppression  [Clear All Filters]
B
Baker, KS, Bresters D, Sande JE.  2010.  The burden of cure: long-term side effects following hematopoietic stem cell transplantation (HSCT) in children.. Pediatric clinics of North America. 57(1):323-42. Abstract
C
Cutler, C, Kesselheim A, Gabardi S, Andersson BS, Carpenter PA, Khoury HJ, Litzow M, Rowley SD, Lanum S, Leather H et al..  2011.  Generic immunosuppressants in hematopoietic cell transplantation.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 17(3):285-90.
H
Halbert, CL, Standaert TA, Wilson CB, Miller AD.  1998.  Successful readministration of adeno-associated virus vectors to the mouse lung requires transient immunosuppression during the initial exposure.. Journal of virology. 72(12):9795-805. Abstract
I
Inamoto, Y, Flowers MED, Lee SJ, Carpenter PA, Warren EH, Deeg HJ, Storb R, Appelbaum FR, Storer BE, Martin PJ.  2011.  Influence of immunosuppressive treatment on risk of recurrent malignancy after allogeneic hematopoietic cell transplantation.. Blood. 118(2):456-63. Abstract
K
Kahl, C, Mielcarek M, Iwata M, Harkey MA, Storer B, Torok-Storb B.  2004.  Radiation dose determines the degree of myeloid engraftment after nonmyeloablative stem cell transplantation.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 10(12):826-33. Abstract
L
Lange, S, Altmann S, Brandt B, Adam C, Riebau F, Vogel H, Weirich V, Hilgendorf I, Storb R, Freund M et al..  2009.  Investigation of immunological approaches to enhance engraftment in a 1 Gy TBI canine hematopoietic stem cell transplantation model.. Experimental hematology. 37(1):143-50. Abstract
Lee, WS, Suzuki Y, Graves SS, Iwata M, Venkataraman GM, Mielcarek M, Peterson LJ, Ikehara S, Torok-Storb B, Storb R.  2011.  Canine bone marrow-derived mesenchymal stromal cells suppress alloreactive lymphocyte proliferation in vitro but fail to enhance engraftment in canine bone marrow transplantation.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 17(4):465-75. Abstract
Lee, SJ, Astigarraga CC, Eapen M, Artz AS, Davies SM, Champlin R, Jagasia M, Kernan NA, Loberiza FR, Bevans M et al..  2008.  Variation in supportive care practices in hematopoietic cell transplantation.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 14(11):1231-8. Abstract
M
Mathes, DW, Noland M, Graves S, Schlenker R, Miwongtum T, Storb R.  2010.  A preclinical canine model for composite tissue transplantation.. Journal of reconstructive microsurgery. 26(3):201-7. Abstract
Mielcarek, M, Storb R.  2005.  Graft-vs-host disease after non-myeloablative hematopoietic cell transplantation.. Leukemia & lymphoma. 46(9):1251-60. Abstract
Mielcarek, M, Storb R, Georges GE, Golubev L, Nikitine A, Hwang B, Nash RA, Torok-Storb B.  2011.  Mesenchymal stromal cells fail to prevent acute graft-versus-host disease and graft rejection after dog leukocyte antigen-haploidentical bone marrow transplantation.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 17(2):214-25. Abstract
Mielcarek, M, Torok-Storb B, Storb R.  2011.  Pharmacological immunosuppression reduces but does not eliminate the need for total-body irradiation in nonmyeloablative conditioning regimens for hematopoietic cell transplantation.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 17(8):1255-60. Abstract
Mielcarek, M, Burroughs L, Leisenring W, Diaconescu R, Martin PJ, Sandmaier BM, Maloney DG, Maris MB, Chauncey TR, Shizuru JA et al..  2005.  Prognostic relevance of 'early-onset' graft-versus-host disease following non-myeloablative haematopoietic cell transplantation.. British journal of haematology. 129(3):381-91. Abstract
P
Parker, MH, Kuhr C, Tapscott SJ, Storb R.  2008.  Hematopoietic cell transplantation provides an immune-tolerant platform for myoblast transplantation in dystrophic dogs.. Molecular therapy : the journal of the American Society of Gene Therapy. 16(7):1340-6. Abstract
Pulsipher, MA, Young NS, Tolar J, Risitano AM, Deeg HJ, Anderlini P, Calado R, Kojima S, Eapen M, Harris R et al..  2011.  Optimization of therapy for severe aplastic anemia based on clinical, biologic, and treatment response parameters: conclusions of an international working group on severe aplastic anemia convened by the Blood and Marrow Transplant Clinical Trials Network,. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 17(3):291-9. Abstract
R
Ram, R, Gooley TA, Maloney DG, Press OW, Pagel JM, Petersdorf SH, Shustov AR, Flowers MED, O'Donnell PV, Sandmaier BM et al..  2011.  Histology and time to progression predict survival for lymphoma recurring after reduced-intensity conditioning and allogeneic hematopoietic cell transplantation.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 17(10):1537-45. Abstract
Rankin, VK, Epstein J, Huber MA, Peterson DE, Plemons JM, Redding SS, Sanfillippo NJ, Schubert MM, Sonis ST.  2009.  Oral health in cancer therapy.. Texas dental journal. 126(5):389-97,406-19,422-37.
S
Sangiolo, D, Storb R, Deeg HJ, Flowers MED, Martin PJ, Sandmaier BM, Kiem H-P, Nash RA, Doney K, Leisenring WM et al..  2010.  Outcome of allogeneic hematopoietic cell transplantation from HLA-identical siblings for severe aplastic anemia in patients over 40 years of age.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 16(10):1411-8. Abstract
Shields, LE, Gaur L, Delio P, Potter J, Sieverkropp A, Andrews RG.  2004.  Fetal immune suppression as adjunctive therapy for in utero hematopoietic stem cell transplantation in nonhuman primates.. Stem cells (Dayton, Ohio). 22(5):759-69. Abstract
Shustov, AR, Gooley TA, Sandmaier BM, Shizuru J, Sorror ML, Sahebi F, McSweeney P, Niederwieser D, Bruno B, Storb R et al..  2010.  Allogeneic haematopoietic cell transplantation after nonmyeloablative conditioning in patients with T-cell and natural killer-cell lymphomas.. British journal of haematology. 150(2):170-8. Abstract
Sorror, ML, Leisenring WM, Mielcarek M, Baron F, Diaconescu R, Hogan WJ, Graves SS, Storb R.  2008.  Intensified postgrafting immunosuppression failed to assure long-term engraftment of dog leukocyte antigen-identical canine marrow grafts after 1 gray total body irradiation.. Transplantation. 85(7):1023-9. Abstract